FULC
Price
$5.41
Change
+$0.34 (+6.71%)
Updated
May 8 closing price
Capitalization
292.03M
89 days until earnings call
NTLA
Price
$8.28
Change
+$0.99 (+13.58%)
Updated
May 8 closing price
Capitalization
755.12M
83 days until earnings call
Ad is loading...

FULC vs NTLA

Header iconFULC vs NTLA Comparison
Open Charts FULC vs NTLABanner chart's image
Fulcrum Therapeutics
Price$5.41
Change+$0.34 (+6.71%)
Volume$440.33K
Capitalization292.03M
Intellia Therapeutics
Price$8.28
Change+$0.99 (+13.58%)
Volume$5.37M
Capitalization755.12M
FULC vs NTLA Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. NTLA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongBuy and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (FULC: $5.41 vs. NTLA: $8.28)
Brand notoriety: FULC and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 81% vs. NTLA: 155%
Market capitalization -- FULC: $292.03M vs. NTLA: $755.12M
FULC [@Biotechnology] is valued at $292.03M. NTLA’s [@Biotechnology] market capitalization is $755.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than NTLA.

Price Growth

FULC (@Biotechnology) experienced а +23.52% price change this week, while NTLA (@Biotechnology) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($755M) has a higher market cap than FULC($292M). FULC YTD gains are higher at: 15.106 vs. NTLA (-28.988). FULC has higher annual earnings (EBITDA): -18.24M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. FULC (241M). FULC has less debt than NTLA: FULC (8.63M) vs NTLA (210M). FULC has higher revenues than NTLA: FULC (80M) vs NTLA (57.9M).
FULCNTLAFULC / NTLA
Capitalization292M755M39%
EBITDA-18.24M-523.98M3%
Gain YTD15.106-28.988-52%
P/E RatioN/AN/A-
Revenue80M57.9M138%
Total Cash241M602M40%
Total Debt8.63M210M4%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCNTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARBCX12.070.01
+0.08%
Arbitrage C
PGPRX24.73N/A
N/A
George Putnam Balanced R
LSHCX33.31N/A
N/A
Kinetics Spin-Off and Corp Rest Adv C
FLCOX18.12N/A
N/A
Fidelity Large Cap Value Index
TLORX9.13N/A
N/A
Transamerica Large Value Opps R